Synthesis of Prodrugs of Zidovudine

Chia Nan University of Pharmacy & Science Institutional Repository > 藥理學院 > 2008第五屆海峽化學、生物及材料研討會 > Item 310902800/30501

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/30501

標題:	Synthesis of Prodrugs of Zidovudine
作者:	Xiu-min Wang Li-juan Wang Wen-fang Zhu Xiao Zheng Jing Li Yanyan Liu
貢獻者:	Department of Pharmaceutical Science, Medical College, Xiamen University School of Pharmacy, Heilongjiang University of Traditional Chinese Medicine
日期:	2008-07
上傳時間:	2017-12-04 15:57:20 (UTC+8)
摘要:	Intensive efforts to develop new chemotherapeutic agents effective against the human immunodeficiency virus (HIV), the etiological agent of acquired immunodeficiency syndrome (AIDS). Zidovudine (3’-azido-2’3’-dideoxythymidine, AZT, azidothymidine) is the first FDA-approved drug available for the treatment of patients suffering from AIDS and AIDS-related complex. Treatment of AZT has led to a decrease in the mortality rate and frequency of opportunistic infections in AIDS patients. But AZT has three disadvantages or side effects. They are (1) the short plasma half-life (about 1 hour), (2) significant dose-related toxicity (bone marrow toxicity, severe anemia), (3) on ability to penetrate into brain. In attempts to overcome the problem of rapid elimination and decreased permeability of AZT through the blood brain barrier and to increase its therapeutic efficacy, we have synthesized a variety of 5’-ester of AZT. Here we synthesize the 5’-arachidate of AZT for the first time. The synthesis of prodrugs of zidovudine was showed in Scheme 1. The further study on biological evaluation and pharmaceutical research of these compounds are carrying on.
關聯:	第五屆海峽化學、生物及材料研討會，起迄日：2008/07/21-2008/07/22，地點：嘉南藥理科技大學
显示于类别:	[藥理學院] 2008第五屆海峽化學、生物及材料研討會

文件中的档案:

档案	描述	大小	格式	浏览次数
C21.pdf		342Kb	Adobe PDF	289	检视/开启

在CNU IR中所有的数据项都受到原著作权保护.

TAIR相关文章

数据加载中.....